Dockets
Federal rulemakings, soonest-closing first — each gathers its documents and comments.
Agency ▾
Clinical Pharmacology Considerations for Peptide Drug Products; Draft Guidance for Industry; Availability
2 awaiting analysis
Formal Meetings Between the Food and Drug Administration and Sponsors or Applicants of Prescription Drug User Fee Act Products
8 awaiting analysis
Taxes on Taxable Distributions From Donor Advised Funds Under Section 4966 (REG-142338-07)
Examining the Effectiveness of Lane Departure Warning and Lane Keep Assist Advanced Driver Assistance Systems for Improving Driver Response.
Notice of Intent to Prepare an Environmental Impact Statement Chesapeake Bay Crossing Study: Tier 2 NEPA
Corporate Alternative Minimum Tax Applicable After 2022 (REG-112129-23)
9 awaiting analysis
Hazardous Materials: Modal Regulatory Reform Initiatives (RRTF) [HM-265]
13 awaiting analysis
Notice of Proposed Policy Statement Regarding the Applicability of FTA’s Drug and Alcohol Testing Program to Transportation Network Companies
Protocol Deviations for Clinical Investigations of Drugs, Biological Products, and Devices; Draft Guidance for Industry; Availability
49 CFR Part 523 Test Procedure Technical Workshop and Demonstration
2 awaiting analysis
ADS-equipped Vehicle Safety, Transparency, and Evaluation Program
33 awaiting analysis
Considerations for the Use of Artificial Intelligence to Support Regulatory Decision-Making for Drug and Biological Products; Draft Guidance for Industry; Availability; Agency Information Collection Activities; Proposed Collection; Comment Request
36 awaiting analysis